ROS-responsive nanoparticles to extend the lifetime of anti-angiogenic drugs

被引：0
|
作者：
Almutairi, Adah [1 ,2 ]
Viet Anh Nguyen Huu [3 ]
Luo, Jing [4 ]
Patel, Sherrina [4 ]
Lux, Caroline de Gracia [1 ]
Zhang, Kang [4 ]
机构：
[1] Univ Calif San Diego, Skaggs Sch Pharm & Pharm Sci, La Jolla, CA USA
[2] Univ Calif San Diego, KACST UCSD Ctr Exc Nanomed & Engn, La Jolla, CA USA
[3] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA USA
[4] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 453 choroid: neovascularization; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
469
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ROS-responsive ADPH nanoparticles for image-guided surgery
    Sun, Kangjun
    Xu, Ruitong
    Xue, Bingyan
    Liu, Pengfei
    Bai, Jianan
    Tian, Ye
    Li, Xiaolin
    Tang, Qiyun
    FRONTIERS IN CHEMISTRY, 2023, 11
  • [22] Clinical aspects of natural anti-angiogenic drugs
    Neal, CP
    Berry, DP
    Doucas, H
    Manson, MM
    Steward, W
    Garcea, G
    CURRENT DRUG TARGETS, 2006, 7 (03) : 371 - 383
  • [23] Anti-Angiogenic Activity of Drugs in Multiple Myeloma
    Saltarella, Ilaria
    Altamura, Concetta
    Campanale, Carmen
    Laghetti, Paola
    Vacca, Angelo
    Frassanito, Maria Antonia
    Desaphy, Jean-Francois
    CANCERS, 2023, 15 (07)
  • [24] Vascular toxicity associated with anti-angiogenic drugs
    Neves, Karla B.
    Montezano, Augusto C.
    Lang, Ninian N.
    Touyz, Rhian M.
    CLINICAL SCIENCE, 2020, 134 (18) : 2503 - 2520
  • [25] Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?
    De Filippis, Daniele
    Cipriano, Mariateresa
    Esposito, Giuseppe
    Scuderi, Caterina
    Steardo, Luca
    Iuvone, Teresa
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (06) : 807 - 812
  • [26] Clinical pharmacology of anti-angiogenic drugs in oncology
    Gougis, P.
    Wassermann, J.
    Spano, J. P.
    Keynan, N.
    Funck-Brentano, C.
    Salem, J. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 119 : 75 - 93
  • [27] Anti-angiogenic effects of tumor-drugs
    Barendsz-Janson, AF
    Toebes, EAH
    Hillen, HFP
    van Dam-Mieras, MCE
    Griffioen, AW
    ANNALS OF ONCOLOGY, 1998, 9 : 78 - 78
  • [28] Is the toxicity of anti-angiogenic drugs predictive of outcome? A review of hypertension and proteinuria as biomarkers of response to anti-angiogenic therapy
    Horsley, Laura
    Marti, Kalena
    Jayson, Gordon C.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 283 - 293
  • [29] ROS-responsive nanoparticles with selenomethionine for ferroptosis modulation in abdominal aortic aneurysm
    He, Haipeng
    Chen, Lei
    Peng, Jiaxin
    Guo, Jinyan
    Xiao, Xue
    Dou, Chaoxun
    Chen, Huining
    Zhan, Songbiao
    Han, Xue
    Yao, Weifeng
    ISCIENCE, 2025, 28 (03)
  • [30] Exploring synergy between anti-angiogenic drugs and immunotherapy
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (SUPPL 4) : S75 - S76
12345